Kitchener-Waterloo

Walk-in appointments open at all regional COVID-19 vaccine clinics as of Monday

As of Monday, all COVID-19 vaccination clinics run by the Region of Waterloo will accept walk-in appointments for anyone eligible to get their first, second or third dose.

Moderna, Pfizer-BioNTech vaccines available at clinics, appointments needed for Johnson and Johnson

Leonardo Melo, left, a PhD student in mechanical engineering at the University of Guelph, gets a dose of the COVID-19 vaccine at a new clinic at the school on Jan. 5 in this file photo. As of Monday, all people eligible for any dose of the COVID-19 vaccine can get one by walking into any regionally run vaccination clinic. (Kate Bueckert/CBC)

All regionally-run vaccination clinics will accept walk-ins of all ages for first, second or third doses of the COVID-19 vaccine as of Monday.

Vickie Murray, who leads the region's vaccination rollout, said the clinics routinely give Moderna, but the region is anticipating an increase in supply of Pfizer-BioNTech, so people can request that brand if desired. 

Murray said other vaccines, such as AstraZeneca or Janssen, the Johnson and Johnson vaccine, are available by special request through the region's website.

"We certainly do understand that there are some people in the community who are more interested in getting a viral vector vaccine than getting the Pfizer and the Moderna," Murray said during a board of health meeting Wednesday.

Risks with Janssen vaccine: Wang

During a media briefing on Friday, Murray said there have been about 300 people who have expressed interest in the Janssen vaccine.

Dr. Hsiu-Li Wang, the region's medical officer of health, said people who get the single-dose Janssen vaccine are doing so with "informed consent."

"It is not the best option and there are risks with it, more risks with it" than the mRNA vaccines, Wang said. 

In July, the U.S. Centres for Disease Control and Prevention said that the Janssen vaccine may pose a "small possible risk" for people developing and immune-system disorder known as Guillain-Barré syndrome. 

Also, as an adenovirus vector vaccines, both Johnson and Johnson's and AstraZeneca-Oxford's shots carry the risk of rare but potentially serious blood clots.

As of Friday's update, just over 78 per cent of all residents in the region had two doses of the COVID-19 vaccine.